Research Progress - All Articles
Interview with Tonia Rex, PhD
GRF awarded Dr. Tonia Rex the 2012 Shaffer Prize for Innovative Glaucoma Research for her project investigating the effectiveness of a neuroprotective therapy in a model of inherited glaucoma.
Read More »
Collaborative Research to Find a Cure
Based on the success of the original Catalyst for a Cure research team, Glaucoma Research Foundation has assembled a second team of investigators to speed the pace of discovery.
Read More »2012 Research Update from Catalyst for a Cure
The goal of the Catalyst for a Cure research team is to find the earliest cellular events in glaucoma progression and to develop potential new therapies that directly target degeneration of the retina and optic nerve in the disease.
Read More »2012 Research Grants
Glaucoma Research Foundation provides seed money for creative pilot research projects that hold promise. We consider it vital to invest funds in new high-impact research that may lead to major government and philanthropic support.
Read More »Dr. Martin Wax explains GRF's New Research Initiative
In this short video interview, Dr. Martin Wax explains the new “biomarker initiative” that Glaucoma Research Foundation is funding beginning in 2012.
Read More »
2012 Video Update from Catalyst for a Cure
Research updates from the Catalyst For a Cure team of investigators, working collaboratively to speed the cure for glaucoma.
Read More »
Biomarkers for Glaucoma
The identification of a metabolic marker indicating tissue injury with accuracy could potentially help predict glaucoma in patients who do not yet show symptoms of vision loss.
Read More »Catalyst for a Cure: Glaucoma and the Brain
The visual system isn't only the eye. It involves the optic pathways and the brain, and data from recent studies point us in a new direction.
Read More »Citations as Evidence of Research Impact
Catalyst For a Cure principal Investigators Monica Vetter and Nick Marsh-Armstrong discuss why citations are important in scientific research.
Read More »CFC Discovers Window of Opportunity
The Catalyst For a Cure (CFC) principal investigators have identified a "window of opportunity" in the very early stages of glaucoma's progression.
Read More »
